Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.

Pharmacogenomics - 1 Feb 2016

Hettige Nuwan C, de Moraes Gustavo H F, Kennedy James L, De Luca Vincenzo

Abstract excerpt

AIM: In order to administer antipsychotic medication with the most beneficial outcome, the appropriate drug and dose needs to be identified. Though often not considered in pharmacogenetic studies, dosage plays an important role in treatment outcome. This study set out to analyze the association between 109 SNPs and antipsychotic dosage among schizophrenia patients. In a previous study, we tested 134 SNPs in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Genetic Association Studies
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Psychotic Disorders

Share to Schizophrenia

Source

Identifiers

PMID: 26780210
DOI: 10.2217/pgs.15.171

Genes

GABRB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Candidate gene analysis of pharmacodynamic targets for antipsychotic dosage.PMID 26780210Read ↗

Genome-wide association analysis to predict optimal antipsychotic dosage in schizophrenia: a pilot study.Semantic proximity Read ↗

Use of candidate gene markers to guide antipsychotic dosage adjustment.Semantic proximity Read ↗

Polygenic risk score prediction of antipsychotic dosage in schizophrenia.Semantic proximity Read ↗

Pharmacogenetics of AntipsychoticsSemantic proximity Read ↗

Polygenic Liability for Antipsychotic Dosage and Polypharmacy - A Real-World Registry and Biobank StudySemantic proximity Read ↗

An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on PharmacogenomicsSemantic proximity Read ↗

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical ImplicationsSemantic proximity Read ↗

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspectsSemantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

Pharmacogenetics and outcome with antipsychotic drugsSemantic proximity Read ↗

Genomic stratification of clozapine prescription patterns using schizophrenia polygenic scoresSemantic proximity Read ↗

Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.